|
1
|
Ye N, Neumeyer JL, Baldessarini RJ, Zhen X, Zhang A. Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders. Chem Rev 2013; 113:PR123-78. [DOI: 10.1021/cr300113a] [Citation(s) in RCA: 75] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Na Ye
- CAS Key Laboratory of Receptor Research, and Synthetic Organic & Medicinal Chemistry Laboratory (SOMCL), Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China 201203
| | - John L. Neumeyer
- Medicinal Chemistry Laboratory,
McLean Hospital, Harvard Medical School, Massachusetts 02478, United States
| | | | - Xuechu Zhen
- Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, China 215123
| | - Ao Zhang
- CAS Key Laboratory of Receptor Research, and Synthetic Organic & Medicinal Chemistry Laboratory (SOMCL), Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China 201203
| |
Collapse
|
|
2
|
Landge KP, Kim JH, Park WK, Gong JY, Koh HY, Lee HY. Identification of substituted pyrazole constrained arylpiperazines asselective ligands for serotonin 5HT1aand 5HT2areceptors. B KOREAN CHEM SOC 2011. [DOI: 10.5012/bkcs.2011.32.8.2861] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
|
3
|
Larghi EL, Kaufman TS. Synthesis of Oxacycles Employing the Oxa‐Pictet–Spengler Reaction: Recent Developments and New Prospects. European J Org Chem 2011. [DOI: 10.1002/ejoc.201100271] [Citation(s) in RCA: 89] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Enrique L. Larghi
- Institute of Chemistry of Rosario (IQUIR, CONICET‐UNR)and Department of Organic Chemistry, School of Pharmaceuticaland Biochemical Sciences, National University of Rosario, Suipacha 531 (S2002LRK) Rosario, Argentina, Fax: +54‐341‐4370477, ext. 35
| | - Teodoro S. Kaufman
- Institute of Chemistry of Rosario (IQUIR, CONICET‐UNR)and Department of Organic Chemistry, School of Pharmaceuticaland Biochemical Sciences, National University of Rosario, Suipacha 531 (S2002LRK) Rosario, Argentina, Fax: +54‐341‐4370477, ext. 35
| |
Collapse
|
|
4
|
Micheli F, Hamprecht D, Bonanomi G, Di Fabio R, Donati D, Gentile G, Heidbreder C, Prandi A, Tarsi L, Terreni S. [3-Azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonists. Bioorg Med Chem Lett 2010; 20:5491-4. [DOI: 10.1016/j.bmcl.2010.07.073] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2010] [Revised: 07/15/2010] [Accepted: 07/16/2010] [Indexed: 10/19/2022]
|
|
5
|
Micheli F, Andreotti D, Braggio S, Checchia A. A specific and direct comparison of the trifluoromethyl and pentafluoro sulfanyl groups on the selective dopamine D3 antagonist 3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-1-phenyl-3-azabicyclo[3.1.0]hexane template. Bioorg Med Chem Lett 2010; 20:4566-8. [DOI: 10.1016/j.bmcl.2010.06.018] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2010] [Revised: 05/31/2010] [Accepted: 06/02/2010] [Indexed: 11/29/2022]
|
|
6
|
Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization. Bioorg Med Chem Lett 2009; 19:4011-3. [DOI: 10.1016/j.bmcl.2009.06.028] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2009] [Revised: 06/05/2009] [Accepted: 06/08/2009] [Indexed: 01/09/2023]
|
|
7
|
Holmes IP, Micheli F, Gaines S, Lorthioir O, Watson SP, Fabio RD, Gentile G, Heidbreder C, Savoia C, Worby A. Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part one: Lead identification. Bioorg Med Chem Lett 2009; 19:4799-801. [DOI: 10.1016/j.bmcl.2009.06.043] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2009] [Revised: 06/09/2009] [Accepted: 06/11/2009] [Indexed: 10/20/2022]
|
|
8
|
Zhang J, Xiong B, Zhen X, Zhang A. Dopamine D1receptor ligands: Where are we now and where are we going. Med Res Rev 2009; 29:272-94. [DOI: 10.1002/med.20130] [Citation(s) in RCA: 94] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
|
9
|
Micheli F, Bonanomi G, Braggio S, Capelli AM, Damiani F, Di Fabio R, Donati D, Gentile G, Hamprecht D, Perini O, Petrone M, Tedesco G, Terreni S, Worby A, Heidbreder C. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-Fused and hetero-fused systems. Bioorg Med Chem Lett 2008; 18:908-12. [DOI: 10.1016/j.bmcl.2007.12.042] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2007] [Revised: 12/18/2007] [Accepted: 12/19/2007] [Indexed: 10/22/2022]
|
|
10
|
New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems. Bioorg Med Chem Lett 2008; 18:901-7. [DOI: 10.1016/j.bmcl.2007.12.066] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2007] [Revised: 12/18/2007] [Accepted: 12/19/2007] [Indexed: 11/21/2022]
|
|
11
|
Repine JT, Johnson DS, White AD, Favor DA, Stier MA, Yip J, Rankin T, Ding Q, Maiti SN. Synthesis of monofluorinated 1-(naphthalen-1-yl)piperazines. Tetrahedron Lett 2007. [DOI: 10.1016/j.tetlet.2007.05.156] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
|
12
|
Favor DA, Johnson DS, Powers JJ, Li T, Madabattula R. Synthesis of chromanyl and dihydrobenzofuranyl piperazines. Tetrahedron Lett 2007. [DOI: 10.1016/j.tetlet.2007.02.121] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
|
13
|
Zhang A, Neumeyer JL, Baldessarini RJ. Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev 2007; 107:274-302. [PMID: 17212477 DOI: 10.1021/cr050263h] [Citation(s) in RCA: 267] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Affiliation(s)
- Ao Zhang
- Bioorganic and Medicinal Chemistry Laboratory, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
| | | | | |
Collapse
|
|
14
|
Grundt P, Husband SLJ, Luedtke RR, Taylor M, Newman AH. Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR. Bioorg Med Chem Lett 2007; 17:745-9. [PMID: 17095222 PMCID: PMC1851912 DOI: 10.1016/j.bmcl.2006.10.076] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2006] [Revised: 10/24/2006] [Accepted: 10/25/2006] [Indexed: 11/17/2022]
Abstract
A series of analogues of the dopamine D2 receptor antagonist L741,626 were synthesized and evaluated for binding and function at D2 family receptor subtypes. Several analogues showed comparable binding profiles to the parent ligand, however, in general, chemical modification served to reduce D2 binding affinity and selectivity.
Collapse
Affiliation(s)
- Peter Grundt
- Medicinal Chemistry, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA
| | | | | | | | | |
Collapse
|
|
15
|
Filer CN. The synthesis of dopaminergic radioligands labelled with tritium and iodine-125. J Labelled Comp Radiopharm 2007. [DOI: 10.1002/jlcr.1399] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|